AuditLine › HHS OIG › Centers for Medicare and Medicaid Services
HHS OIG recommendation 19-A-06-136.02
We recommend that the Texas Health and Human Services Commission strengthen internal controls to ensure that all eligible physician-administered…
The recommendation, in the publisher's words
We recommend that the Texas Health and Human Services Commission strengthen internal controls to ensure that all eligible physician-administered drugs are billed for rebate.
- Responsible agency
- Centers for Medicare and Medicaid Services
- Issued
- August 21, 2019
- Report
- Texas Did Not Bill Manufacturers for Some Rebates for Physician-Administered Drugs Dispensed to Enrollees of Medicaid Managed-Care Organizations (A-06-17-04001) · find it at HHS OIG
- Kind of report
- Audit
- Agency response
- Concur (as recorded by the publisher)
- Closed
- January 30, 2020 (publisher's date)
- Publisher topics
- Managed Care, Prescription Drug
“Open” and “closed” are the publisher's words. AuditLine repeats them with the date it read them. It does not check whether a recommendation was carried out, and a closed recommendation is not proof that a problem was fixed.
Dated history
- Issued by HHS OIG. (publisher's date)
- Closed, with status “Closed Implemented”. (publisher's date)
- First recorded by AuditLine. (start of AuditLine's own history for this record)
Dates marked "publisher's date" come from the publisher's file. AuditLine's own observations begin November 10, 2026 and are added each time the publisher's file changes.
Other recommendations from this report
3 more, of which 0 are open in the publisher's file.
- We recommend that the Texas Health and Human Services Commission bill manufacturers for the $3,785,737 ($2,202,921 Federal share) in rebates for single-source and top-20 multiple-source…HHS OIG 19-A-06-136.01 · issued Aug 21, 2019 · closed Jan 30, 2020Closed Implemented
- We recommend that the Texas Health and Human Services Commission work with CMS to determine whether the other physician-administered drugs, associated with 160,579 claim lines, were…HHS OIG 19-A-06-136.03 · issued Aug 21, 2019 · closed Feb 19, 2021Closed Implemented
- We recommend that the Texas Health and Human Services Commission work with CMS to determine whether the non-top-20 multiple-source physician-administered drugs were eligible for rebates…HHS OIG 19-A-06-136.04 · issued Aug 21, 2019 · closed Jan 30, 2020Closed Implemented
Source
Open this report in HHS OIG's tracker This publisher's records (CSV)
Official export: https://oig.hhs.gov/recommendations/export-recs/. File read , 4,677 rows,
SHA-256 664fdfb3658ecb72…. HHS OIG's status, response, dates and potential-savings labels are the publisher's own claims.